Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230
more »
- Hospital for Sick Children Research Institute, Toronto, ON (Canada)
- Radboud Univ., Nijmegen (Netherlands)
- TropIQ Health Sciences, Nijmegen (Netherlands)
- AbCellera Biologics Inc., Vancouver, BC (Canada)
- PATH Malaria Vaccine Initiative, Washington, DC (United States)
- Infectious Disease Research Collaboration, Kampala (Uganda)
- Univ. of California, San Francisco, CA (United States)
- Stanford Univ., CA (United States)
- Hospital for Sick Children Research Institute, Toronto, ON (Canada); Univ. of Toronto, ON (Canada)
Pfs230 is essential for Plasmodium falciparum transmission to mosquitoes and is the protein targeted by the most advanced malaria-transmission-blocking vaccine candidate. Prior understanding of functional epitopes on Pfs230 is based on two monoclonal antibodies (mAbs) with moderate transmission-reducing activity (TRA), elicited from subunit immunization. Here, we screened the B cell repertoire of two naturally exposed individuals possessing serum TRA and identified five potent mAbs from sixteen Pfs230 domain-1-specific mAbs. Structures of three potent and three low-activity antibodies bound to Pfs230 domain 1 revealed four distinct epitopes. Highly potent mAbs from natural infection recognized a common conformational epitope that is highly conserved across P. falciparum field isolates, while antibodies with negligible TRA derived from natural infection or immunization recognized three distinct sites. Our study provides molecular blueprints describing P. falciparum TRA, informed by contrasting potent and non-functional epitopes elicited by natural exposure and vaccination.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- Bill & Melinda Gates Foundation; European Research Council (ERC); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2423565
- Journal Information:
- Immunity, Journal Name: Immunity Journal Issue: 2 Vol. 56; ISSN 1074-7613
- Publisher:
- Cell PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire
Journal Article
·
Mon Feb 13 19:00:00 EST 2023
· Immunity
·
OSTI ID:2423454
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle
Journal Article
·
Thu Aug 17 20:00:00 EDT 2023
· npj Vaccines
·
OSTI ID:2422630
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire
Journal Article
·
Sun Nov 27 19:00:00 EST 2022
· PLoS Pathogens
·
OSTI ID:2470050